05:11 AM EDT, 04/23/2024 (MT Newswires) -- Cidara Therapeutics ( CDTX ) reported a Q4 net loss late Monday of $0.04 per diluted share, compared with a net loss of $0.19 a year earlier.

Three analysts polled by Capital IQ expected a loss of $0.10.

Revenue for the quarter that ended Dec. 31 was $17.6 million, up from $10.2 million a year earlier.

Three analysts surveyed by Capital IQ expected $11.5 million.

Shares of the company traded 12% higher in premarket activity.